期刊文献+

儿童急性巨核细胞白血病 被引量:6

Childhood Acute Megakaryoblastic Leukemia
下载PDF
导出
摘要 本研究通过实例分析儿童急性巨核细胞白血病(AMKL)的临床、病理和生物学特征。用骨髓细胞涂片观察细胞的形态;用流式细胞技术和免疫组织化学方法检测肿瘤细胞的免疫表型。结果表明:本例以发热、出血、肝脾淋巴结肿大为主要临床症状,白细胞增多伴两系血细胞减少,骨髓干抽,骨髓原始巨核细胞异常增生超过30%,原始细胞的免疫分型为CD41+CD61+。骨髓活检显示,髓内增生的单个核大细胞为CD42b+。最后诊断为急性巨核细胞白血病。结论儿童急性巨核细胞白血病较为少见,容易误诊,预后不好;免疫分型和免疫组织化学检测有助于该病的早期诊断和预后评估。 The aim of this study was to investigate the clinical, pathological and biological features of acute megakaryoblastic leukemia in childhood. The morphology of cells was observed by means of bone marrow smear; the immunophenotype was detected by flow cytometry and immunohistochemistry assay. The results indicated that the fever, hemorrhage, hepatosplenomegaly and lymphadenopathy in this case were the primary presentations accompanying by leukocytosis, anemia and thrombocytopenia. An adequate marrow aspirate could not be obtained. At the time of diagnosis, the bone marrow had more than 30% megakaryoblasts in nucleated cells. Flow cytometric analysis revealed the dual expression of CD41 and CD61 by tumor cells in bone marrow. The histopathological examination of bone marrow demonstrated infiltration of large-sized CD42b^+ cells. According to all above mentioned results, this case was diagnosed as acute megakaryoblastic leukemia. In conclusion, childhood acute megakaryoblastic leukemia is a rare and easily misdiagnosed disease with poor prognosis. Flow cytometry analysis and immunohistochemistry assay of bone marrow can help in detecting this leukemia subtype and evaluating its prognosis.
出处 《中国实验血液学杂志》 CAS CSCD 2007年第3期528-532,共5页 Journal of Experimental Hematology
关键词 白血病 急性巨核细胞白血病 儿童 leukemia acute megakaryoblastic leukemia childhood
  • 相关文献

参考文献17

  • 1Lewis SM,Szur L.Malignant myelosclerosis.Br Med J,1963;2:472-477 被引量:1
  • 2Hassan HT,Freund M.Characteristic biological features of human megakaryoblastic leukemia cell lines.Leuk Res,1995;19:589-594 被引量:1
  • 3Barnard DR,Alonzo TA,Gerbing RB,et al.Comparison of childhood myelodysplastic syndrome,AML FAB M6 or M7,CCG 2891:Report from the Children's Oncology Group.Pediatr Blood Cancer,2006;[Epub ahead of print] 被引量:1
  • 4Carroll A,Civin C,Schneider N,et al.The t(1;22)(p13;q13)is nonrandom and restricted to infants with acute megakaryoblastic leukemia:a Pediatric Oncology Group Study.Blood,1991;78:748-752 被引量:1
  • 5Lion T,Haas OA,Harbott J,et al.The translocation t(1;22)(p13;q13)is a noorandom marker specifically associated with acute megakaryocytic leukemia in young children.Blood,1992;79:3325-3330 被引量:1
  • 6Creutzig U,Harbott J,Sperling C,et al.Clinical significance of surfaceantigen expressionin children with acute myeloid leukemia:results of study AML-BFM-87.Blood,1995;86:3097-3108 被引量:1
  • 7Paredes-Aguilera R,Romero-Guzman L,Lopez-Santiago N,et al.Biology,clinical,and hematologic features of acute megakaryoblastic leukemia in children.Am J Hematol,2003;73:71-80 被引量:1
  • 8Pagano L,Pulsoni A,Vignetti M,et al.Acute megakaryoblastic leukemia:experience of GIMEMA trials.Leukemia,2002;16:1622-1626 被引量:1
  • 9汪亚伦,王彤,许凤,冮岩,王杰.伴有6;9染色体易位急性髓系白血病患者DEK-CAN融合基因表达分析[J].中国实验血液学杂志,2006,14(2):232-236. 被引量:8
  • 10李志刚,吴敏媛,朱平,胡亚美.白血病29种染色体畸变形成的融合基因分析[J].中华儿科杂志,2001,39(11):682-685. 被引量:32

二级参考文献16

  • 1龚辉,刘文励,周剑峰,徐慧珍.急性白血病患者骨髓细胞CHFR基因表达及其临床意义[J].中华医学杂志,2005,85(16):1085-1088. 被引量:2
  • 2Campana D,Blood,1995年,85卷,1416页 被引量:1
  • 3Shapira MY,Hirshberg B,Amir G,et al.6 ;9 translocation in myelodysplastic syndrome.Cancer Genet Cytogenet,1999; 112:57 -59. 被引量:1
  • 4Boer J,Mahmoud H,Raimondi S,et al.Loss of the DEK-CAN fusion transcript in a child with t(6;9) acute myeloid leukemia following chemotherapy and allogeneic bone marrow transplantation.Leukemia,1997; 11:299 -300. 被引量:1
  • 5Potter MN,Cross NC,van-Dongen JJ,et al.Molecular evidence of minimal residual disease after treatment for leukaemia and lymphoma:an updated meeting report and review.Leukemia,1993;7:1302-1314. 被引量:1
  • 6Yokota H,Kitamura K.The genetic diagnosis of hematopoietic malignancy by polymerase chain reaction method.Rinsho Byori,2000; 48:708 -715. 被引量:1
  • 7Garcon L,Libura M,Delabesse E,et al.DEK-CAN molecular monitoring of myeloid malignancies could aid therapeutic stratification.Leukemia,2005; 19:1338-1344. 被引量:1
  • 8Makita M,Azuma T,Hamaguchi H,et al.Leukemia-associated fusion proteins,dek-can and bcr-abl,represent immunogenic HLADR-restricted epitopes recognized by fusion peptide-specific CD4 +T lymphocytes.Leukemia,2002; 16:2400-2407. 被引量:1
  • 9von-Lindem M,van-Baal S,Wiegant J,et al.Can,a putative oncogene associated with myeloid leukemogenesis,may be activated by fusion of its 3' half to different genes:characterization of the set gene.Mol Cell Biol,1992; 12:3346-3355. 被引量:1
  • 10Shearer BM,Knudson RA,Flynn HC,et al.Development of a DFISH method to detect DEK/CAN fusion resulting from t (6;9)(p23 ;q34) in patients with acute myelogenous leukemia.Leukemia,2005; 19:126-131. 被引量:1

共引文献38

同被引文献44

引证文献6

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部